As proven regeneration specialists, SOG Ltd has developed its own unique consultancy service ‘Fusion’ which offers advice and guidance to organisations considering closing or down-sizing sites. Fusion identifies whether there are viable, cost-effective options to regenerate such sites that may protect the facilities and secure employment.
If you’re interested in finding out more about Fusion, please click the ‘Learn More’ button below.Learn More
University College London were looking to relocate their trial research facility and develop a major purpose-built research building. The facility conducts experiments regarding the movement of people through specifically public transport spaces. Access to people and a thriving business hub were key necessities.Download
Following a review of its global business pharmaceutical company Sanofi announced the intention to close its manufacturing plant at Fawdon in the north-east of England.
Sanofi had a commitment to approaching site closure in a way that treats staff fairly and recognises the company’s Corporate Social Responsibility.
Sanofi appointed SOG’s Fusion Team to consider the various options for Fawdon in the lead up to closure. SOG was selected due to its success in coordinating the sale and regeneration of a major Sanofi manufacturing site in Dagenham, east London, which led to SOG creating Londoneast-uk Business and Technical Park.Download
Novartis was exiting a modern vaccine packaging facility located in Speke Liverpool. The facility was a modern new-build consisting of temperature controlled warehouse, sterile manufacturing facilities, offices and staff welfare facilities.Download
Astra Zeneca was exiting a very large research facility set in parkland. The site consisted of a number of separate buildings including warehousing, offices, conferencing, and staff welfare and specialist science research facilities.Download